STAT

OCTOBER 23, 2023

The risks of severe neonatal morbidity, neonatal death, and admission to the neonatal intensive care unit were all significantly lower during the first month of birth in infants whose mothers were vaccinated against Covid-19, and protection against the virus continued for up to six months after birth, according to a new study published Monday in JAMA (..)

Vaccines 364

Vaccines Immunity Immunization 364

STAT

AUGUST 21, 2023

The Food and Drug Administration on Monday approved a Pfizer vaccine that aims to protect newborns against RSV by vaccinating pregnant people in the latter part of pregnancy. The vaccine, Abrysvo, has also been approved for use in adults 60 and older to protect them against respiratory syncytial virus. Read the rest…

Vaccines 246

Vaccines Immunity Immunization 246

European Pharmaceutical Review

MARCH 6, 2023

The first clinical trial of any subunit tuberculosis (TB) vaccine in a temperature-stable form has found that ID93+GLA-SE, a freeze-dried vaccine, was safe. The recombinant subunit vaccine is made from four proteins of Mycobacterium tuberculosis bacteria combined with GLA-SE, an immune-stimulating adjuvant.

Immunity 103

Immunity Immunization Vaccines Communication 103

STAT

JUNE 14, 2024

Nearly nine in 10 Americans strongly believe in the overall value of childhood vaccines. Reflecting the value communities place on them, every state and the District of Columbia require children to get vaccinated against certain diseases before they start school, including measles, mumps, polio, tetanus, whooping cough, and chickenpox.

Vaccines 346

Vaccines Immunity Immunization 346

European Pharmaceutical Review

JUNE 13, 2023

If approved, VLA1553 could become the first licensed chikungunya vaccine” A single vaccination of VLA1553 has been shown to produce neutralising antibody levels, thought to protect against chikungunya disease in 99 percent of Phase III trial participants. What did the chikungunya vaccine study results show?

Immunity 105

Immunity Immunization Vaccines 105

STAT

MAY 13, 2024

The number of children who received their routine vaccinations declined during the pandemic, so public health officials have been focusing on getting kids back up to date. They should also be paying attention to adults as a new, first-of-its-kind report quantifying the economic impact of adult immunizations makes clear.

Vaccines 362

Vaccines Immunization Immunity 362

STAT

JANUARY 21, 2024

LONDON — Starting Monday, a new, highly effective malaria vaccine will be rolled out for the first time, as an immunization campaign for children kicks off in Cameroon — a day that global health officials say marked a historic step in the decades-long quest to protect people from one of the world’s deadliest infections.

Vaccines 364

Vaccines Immunization Immunity 364

STAT

FEBRUARY 15, 2024

The Department of Health and Human Services announced Thursday that it is filling eight vacancies, including the chairmanship, on an important advisory panel on vaccine policy that was down to less than half of its normal roster for months.

Vaccines 353

Vaccines Immunity Immunization 353

STAT

AUGUST 16, 2024

… Pfizer and BioNTech disclosed that their combined mRNA vaccine candidate against influenza and Covid-19 showed a lower immune response against one type of influenza, influenza B, in a Phase 3 trial, a setback for the vaccine , STAT says. The vaccine developer has about 300,000 doses ready for shipping immediately.

Vaccines 272

Vaccines Immunity Immunization 272

STAT

APRIL 10, 2024

SAN DIEGO — Cancer vaccines have traveled a potholed road over the last decade. The promise has long been an affordable, personalized cancer vaccine that could train the immune system to recognize proteins from cancer cells and, subsequently, destroy the tumor.

Vaccines 364

Vaccines Immunization Immunity Drug Development 364

STAT

FEBRUARY 29, 2024

The new vaccines that protect older adults against respiratory syncytial virus, or RSV, may be linked to a small increased risk of developing Guillain-Barré syndrome, new data from the Centers for Disease Control and Prevention and the Food and Drug Administration suggest. Read the rest…

Vaccines 358

Vaccines Immunization Immunity 358

Express Pharma

JULY 7, 2023

Researchers and clinicians from the University of Sheffield and Sheffield Teaching Hospitals NHS Foundation Trust are part of the ongoing OCTAVE (Observational Cohort Trial-T-cells Antibodies and Vaccine Efficacy in SARS-CoV-2) trial, which is led by the Universities of Glasgow, Birmingham and Oxford and a consortium of leading UK institutions.

Immunity 93

Immunity Immunization Vaccines Hospitals 93

Express Pharma

JUNE 20, 2023

The vaccine efforts of the COVID-19 pandemic highlighted our knowledge about gaps in the immune system. Reductionist systems, such as genetically identical inbred mice, have long been the choice for immunology research, which focuses on studying the cells, tissues, and organs that make up the immune system.

Immunity 103

Immunity Immunization Vaccines Hospitals 103

STAT

MAY 17, 2024

HIV has long stumped immunologists looking to develop an effective vaccine. All of the most promising approaches pioneered in the past three and a half decades have ultimately failed, and only a few months ago, the last trial expected to potentially deliver a vaccine within this decade was shut down.

Vaccines 357

Vaccines Immunization Immunity 357

STAT

NOVEMBER 8, 2023

Vaccines work well to prevent cancers caused by the human papillomavirus (HPV). So well, in fact, that it may be time to review HPV screening protocols, according to the somewhat provocative conclusion of a new study examining the occurrence of genital HPV types eight years after immunization, published today in Cell Host & Microbe.

Vaccines 364

Vaccines Immunization Immunity 364

STAT

NOVEMBER 24, 2022

An experimental influenza vaccine developed using messenger RNA technology appears capable of inducing what should be a protective immune response against all known subtypes of flu, at least in animals. If the work is translated into humans it could turn out to be a version of a long-sought universal vaccine.

Vaccines 336

Vaccines Immunity Immunization Hospitals 336

STAT

NOVEMBER 10, 2023

An expert panel that advises the United Kingdom on vaccine policy has recommended using a meningitis B vaccine to try to bring down spiking rates of gonorrhea. would be the first country to use the meningitis B vaccine for this purpose. If adopted, the U.K.

Vaccines 363

Vaccines Immunity Immunization 363

Pharmacy Joe

JUNE 2, 2024

In this episode, I’ll discuss the use of tetanus immune globulin. Subscribe on iTunes , Android , or Stitcher Tetanus Immune Globulin can be part of successful tetanus post-exposure prophylaxis for certain patients as well as tetanus treatment. Peak concentrations are reached in 2 days and the half-life is 23 days.

Immunity 52

Immunity Immunization Vaccines Hospitals 52

World Pharma News

MAY 10, 2024

Scientists from Trinity College Dublin have made an important breakthrough that offers promise for developing new immune therapies for cancer. They have discovered that a vaccine adjuvant - or "booster" - called C100 promotes potent anti-tumour immunity when it is injected directly into tumours in an animal model.

Immunity 71

Immunity Immunization Vaccines 71

STAT

JUNE 26, 2024

Makers of RSV vaccines for older adults saw their plans to try to expand usage hit a significant hurdle on Wednesday, when an expert committee that advises the Centers for Disease Control and Prevention on vaccines recommended changes that will likely see fewer older adults qualify for insurance coverage for these products.

Vaccines 330

Vaccines Immunization Immunity 330

STAT

FEBRUARY 29, 2024

Flu vaccine appears to be offering reasonable levels of protection this winter, with particularly strong levels in children, new data from the Centers for Disease Control and Prevention suggest. Read the rest…

Vaccines 289

Vaccines Immunity Immunization 289

World Pharma News

OCTOBER 10, 2023

A University of Massachusetts Amherst team has demonstrated in theory that a protein antigen from a childhood vaccine can be delivered into the cells of a malignant tumor to refocus the body’s immune system against the cancer, effectively halting it and preventing its recurrence.

Immunity 87

Immunity Immunization Vaccines 87

STAT

MAY 5, 2023

A new study sheds light on what may be causing very rare cases of heart inflammation in young men after receiving an mRNA Covid vaccine. But the study , published Friday in Science Immunology, doesn’t find evidence for any of these mechanisms.

Vaccines 364

Vaccines Immunity Immunization 364

STAT

OCTOBER 2, 2023

Last month, the first volunteer was injected with an HIV vaccine he spent over 20 years designing.   Truthfully, though, Picker isn’t sure his HIV vaccine stands much of a chance.   Truthfully, though, Picker isn’t sure his HIV vaccine stands much of a chance. It’s prototype No.

Vaccines 355

Vaccines Immunization Immunity 355

STAT

JULY 17, 2023

Global childhood immunization coverage has nearly rebounded to pre-pandemic levels, according to a new report, with 4 million more children receiving full immunization in 2022 compared to 2021. But the report, released Monday by UNICEF and the World Health Organization (WHO), also shows that recovery is lagging in low-income countries.

Vaccines 246

Vaccines Immunity Immunization 246

NY Times

JULY 4, 2021

France is handing out third shots of the two-dose vaccines to cancer patients and others with immune system impairments. In the United States, patients like these are on their own.

Immunity 89

Immunity Immunization Vaccines 89

STAT

FEBRUARY 8, 2024

vaccination policy appears to be atrophying, jeopardizing timely decision-making on how vaccines should be used in this country. The Advisory Committee on Immunization Practices, which has in recent years been a 15-person panel, has eight vacancies — one of which dates back more than a year.

Vaccines 363

Vaccines Immunization Immunity 363

STAT

JUNE 7, 2023

LONDON — The European Commission approved GSK’s RSV vaccine, the company said Wednesday, bringing to the market the first such tool that can protect older adults from the common respiratory bug.     The vaccine, Arexvy, was authorized for adults 60 and older. Arexvy won U.S. Read the rest…

Vaccines 246

Vaccines Immunity Immunization 246

STAT

DECEMBER 12, 2022

to receive a Covid-19 vaccine outside of a clinical trial. A study released Tuesday by the Commonwealth Fund shows that in those two years, the Covid vaccines have averted over 3 million deaths in the U.S. Without vaccines, the country would have experienced four times as many deaths, 1.5 The vaccines also saved the U.S. $1

Vaccines 359

Vaccines Hospitals Immunization Immunity 359

STAT

JUNE 21, 2023

A panel of experts  that advises the Centers for Disease Control and Prevention on vaccinations opted Wednesday not to recommend that all seniors get a vaccine to protect against RSV.

Vaccines 246

Vaccines Immunity Immunization 246

pharmaphorum

JULY 5, 2021

Shahrokh Shabahang discusses why we need a personalised approach to COVID-19 immunity testing. While these numbers do tell us something about the relative immunity of the population writ large, they don’t tell us anything about our own, personal immune profiles. However, we’ve also found a number of outliers.

Immunity 105

Immunity Immunization Health and Personal Care Stores Vaccines 105

STAT

APRIL 19, 2023

An expert panel that advises the Centers for Disease Control and Prevention on vaccination policy informally endorsed a plan Wednesday to offer an additional Covid-19 booster shot to people 65 and older as well as people who are immunocompromised, and to simplify the Covid vaccine schedule.

Vaccines 266

Vaccines Immunity Immunization 266

STAT

MAY 18, 2023

A committee of vaccine experts voted to recommend the Food and Drug Administration approve Pfizer’s maternal RSV vaccine on Thursday, though the panel expressed some safety concerns. Read the rest…

Vaccines 266

Vaccines Immunity Immunization 266

Pharma Times

JULY 28, 2021

AC Immune is set to acquire Affiris’ entire portfolio of therapeutics targeting alpha-synuclein

Immunity 117

Immunity Immunization Vaccines 117

STAT

MARCH 28, 2023

A panel of experts that advises the World Health Organization on vaccine use suggested Tuesday that countries no longer need to consider offering additional Covid-19 boosters to people at medium or low risk of becoming seriously ill if they contract the SARS-CoV-2 virus.

Vaccines 330

Vaccines Immunity Immunization 330

STAT

OCTOBER 2, 2023

and Europe are ramping up their campaigns urging eligible people to get another vaccine round against Covid and flu, promoting the immunizations as people’s best way to protect themselves and reduce pressure on health systems during what is expected to be another tough winter. LONDON — Health officials in the U.K.

Vaccines 316

Vaccines Immunization Immunity 316

Pharmacy Times

AUGUST 2, 2023

A panel of experts review the criteria used to select a specific high-dose flu vaccine formulation for immunization.

Immunity 49

Immunity Immunization Vaccines 49